Literature DB >> 18080040

Molecular basis of insulin action.

José Luis González-Sánchez1, Manuel Serrano-Ríos.   

Abstract

Insulin is the main anabolic and anticatabolic hormone in mammals. The stimulatory effect of insulin on glucose uptake in muscle and adipose tissue is a consequence of the rapid translocation of GLUT4 glucose transporters from an intracellular site to the cell surface. The actions of insulin are initiated by hormone binding to its cell surface receptors. Insulin receptors are ligand-stimulated protein tyrosine kinases and phosphorylate a number of proteins, known as insulin receptor substrate proteins. Insulin resistance has been recognized as a main pathogenic factor in the development of type 2 diabetes, and has been associated with dyslipidemia, hypertension, endothelial dysfunction, inflammation and coagulative state. The current challenge is the study of impaired insulin signaling pathways leading to beta-cell dysfunction and its progression to type 2 diabetes, as well as control of chronic inflammation processes that may improve insulin action. (c) 2007 Prous Science. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18080040     DOI: 10.1358/dnp.2007.20.8.1157615

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  8 in total

1.  Erythritol reduces small intestinal glucose absorption, increases muscle glucose uptake, improves glucose metabolic enzymes activities and increases expression of Glut-4 and IRS-1 in type 2 diabetic rats.

Authors:  Chika Ifeanyi Chukwuma; Ramgopal Mopuri; Savania Nagiah; Anil Amichund Chuturgoon; Md Shahidul Islam
Journal:  Eur J Nutr       Date:  2017-08-02       Impact factor: 5.614

Review 2.  Insulin plus incretin: A glucose-lowering strategy for type 2-diabetes.

Authors:  Bo Ahrén
Journal:  World J Diabetes       Date:  2014-02-15

3.  Immune and Inflammatory Signaling Pathways in Exercise and Obesity.

Authors:  Karsten Krüger; Frank C Mooren; Klaus Eder; Robert Ringseis
Journal:  Am J Lifestyle Med       Date:  2014-10-27

Review 4.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 5.  Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.

Authors:  Suzanne M de la Monte
Journal:  Eur Neuropsychopharmacol       Date:  2014-06-28       Impact factor: 4.600

6.  Abnormal carbohydrate metabolism in a canine model for muscular dystrophy.

Authors:  Andressa R Amaral; Márcio A Brunetto; Marina P Brólio; Daniela S Cima; Maria A Miglino; João Paulo F Santos; Carlos E Ambrósio
Journal:  J Nutr Sci       Date:  2017-11-23

Review 7.  Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease.

Authors:  Sanjay Kalra; Ambika Gopalakrishnan Unnikrishnan; Manash P Baruah; Rakesh Sahay; Ganapathi Bantwal
Journal:  Diabetes Metab Syndr Obes       Date:  2021-01-15       Impact factor: 3.168

Review 8.  Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications.

Authors:  Francesca Ligorio; Luca Zambelli; Giovanni Fucà; Riccardo Lobefaro; Marzia Santamaria; Emma Zattarin; Filippo de Braud; Claudio Vernieri
Journal:  Ther Adv Med Oncol       Date:  2022-03-08       Impact factor: 8.168

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.